Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

4.07
0.0000
Volume:420.97K
Turnover:1.70M
Market Cap:455.84M
PE:-2.58
High:4.11
Open:4.06
Low:3.98
Close:4.07
52wk High:4.74
52wk Low:1.05
Shares:112.00M
Float Shares:92.24M
Volume Ratio:0.47
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5758
EPS(LYR):-1.6246
ROE:-705.53%
ROA:-22.99%
PB:-2.29
PE(LYR):-2.51

Loading ...

ADC Therapeutics Sa : H.c. Wainwright Cuts Target Price to $7 From $8

THOMSON REUTERS
·
Oct 16

ADC Therapeutics SA Publishes Corporate Presentation Highlighting ZYNLONTA® Expansion and Advancements in ADC Pipeline

Reuters
·
Oct 13

ADC Therapeutics Announces $60 Million Private Placement Led by TCGX and Redmile Group

Reuters
·
Oct 13

RBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)

TIPRANKS
·
Oct 10

Guggenheim Sticks to Their Buy Rating for ADC Therapeutics (ADCT)

TIPRANKS
·
Oct 08

ADC Therapeutics Grants Stock Options to New Employees Under Inducement Plan to Drive Company Growth

Reuters
·
Oct 02

ADC Therapeutics SA Unveils Corporate Presentation Highlighting ZYNLONTA Expansion and Progress on Next-Generation PSMA-Targeting ADC

Reuters
·
Sep 30

ADC Therapeutics SA Announces New Employee Inducement Plan with Option Grants to Motivate and Reward Performance

Reuters
·
Sep 03

ADC Therapeutics SA to Present at Cantor Global Healthcare Conference 2025

Reuters
·
Aug 27

ADC Therapeutics SA Reports Increased Net Loss of $56.6 Million in Q2 2025, EPS Down to $0.50; Product Revenues Rise to $18.1 Million

Reuters
·
Aug 12

BRIEF-ADC Therapeutics Q2 Income From Operations USD -44.147 Million Vs. IBES Estimate USD -44.5 Million

Reuters
·
Aug 12

ADC Therapeutics - Q2 Adj Loss per Share $0.25

THOMSON REUTERS
·
Aug 12

ADC Therapeutics Q2 Revenue USD 18.839 Million VS. Ibes Estimate USD 17.9 Million

THOMSON REUTERS
·
Aug 12

ADC Therapeutics Q2 Net Income USD -56.646 Million VS. Ibes Estimate USD -53.3 Million

THOMSON REUTERS
·
Aug 12

ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

THOMSON REUTERS
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

ADC Therapeutics SA to Release Second Quarter 2025 Financial Results

Reuters
·
Aug 06

ADC Therapeutics SA Announces New Inducement Plan with Stock Option Grants to Attract Top Talent

Reuters
·
Aug 02

ADC Therapeutics SA expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
Aug 01

ADC Therapeutics Announces New Inducement Plan Granting Stock Options to New Employee

Reuters
·
Jul 02